Article info
PDFClinical and epidemiological research
Extended report
Anticitrullinated protein/peptide antibody multiplexing defines an extended group of ACPA-positive rheumatoid arthritis patients with distinct genetic and environmental determinants
- Correspondence to Dr Johan Rönnelid, Department of Immunology, Genetics and Pathology, Uppsala University, SE-75185 Uppsala, Sweden; johan.ronnelid{at}igp.uu.se
Citation
Anticitrullinated protein/peptide antibody multiplexing defines an extended group of ACPA-positive rheumatoid arthritis patients with distinct genetic and environmental determinants
Publication history
- Received May 12, 2017
- Revised September 14, 2017
- Accepted September 15, 2017
- First published October 25, 2017.
Online issue publication
January 12, 2018
Article Versions
- Previous version (25 October 2017).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© Article author(s) (or their employer(s) unless otherwise stated in the text of the article) 2018. All rights reserved. No commercial use is permitted unless otherwise expressly granted.